February 23, 2017 - Beyond Type 1 Provides Grant to ViaCyte to Support Research and Development of Cell Replacement Therapies for Type 1 Diabetes Read More

February 21, 2017 - ViaCyte to Present at Four Upcoming Healthcare Events Read More

January 25, 2017 - Johns Hopkins and AAMI publish on implementation of ViSi Mobile System Read More

January 6, 2017 - Calcimedica Initiates Phase 1 Clinical Studies For CRAC Channel Inhibitor Read More

January 4, 2017 - Twenty-two Patients are Added to ViaCyte’s Intellectual Property Portfolio Read More

January 1, 2017 - Recordings available from 2016 AAMI Foundation Event Read More

December 7, 2016 - Codman Neuro Announces Acquisition Of Pulsar Vascular Inc., Expanding Neurovascular Treatment For Patients With Complex Aneurysms Read More

November 17, 2016 - Diazon Pharmaceutical’s anti-cancer agent DZ-2384 mechanism for high activity and low neurotoxicity published by McGill researchers in Science Translational Medicine Read More

November 16, 2016 - Glycomine, Inc. Announces $12 Million Series A Financing to Advance a New Generation of Replacement Therapies for Rare Diseases Read More

November 15, 2016 - San Francisco VA, UCSF And CalciMedica, Inc. Present Results On CRAC Channel Inhibitors In Traumatic Brain Injury Model At Neuroscience Meeting Read More